SCHEMBL9669672

SCHEMBL9669672

COc1ccc(OC(=O)O)c(OC)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.63
CA1 P00915 2/20 0.63
CA2 P00918 2/20 0.63
CA7 P43166 2/20 0.63
CA9 Q16790 2/20 0.63
CA14 Q9ULX7 2/20 0.63
HSD17B10 Q99714 1/20 0.54
KMT2A Q03164 3/20 0.53
ALDH1A1 P00352 6/20 0.52
MAPT P10636 3/20 0.51
HTT P42858 2/20 0.51
NPSR1 Q6W5P4 1/20 0.51
GAA P10253 1/20 0.51
LMNA P02545 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
TSHR P16473 1/20 0.50
NPC1 O15118 1/20 0.50
MEN1 O00255 1/20 0.49
JUN P05412 1/20 0.49
NFKB1 P19838 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27655956 0.86 CA12 (0.59) CA12CA1CA2CA7CA9
SCHEMBL9669664 0.85 CA12 (0.63) CA12CA1CA2CA7CA9
SCHEMBL3328971 0.85 TSHR (0.64) CA12CA1CA2CA7CA9
SCHEMBL5167793 0.85 CA12 (0.52) CA12CA1CA2CA7CA9
SCHEMBL7203444 0.84 HIF1A (0.54) CA12CA1CA2CA7CA9
SCHEMBL14734821 0.83 CA12 (0.67) CA12CA1CA2CA7CA9
SCHEMBL4644094 0.83 CA12 (0.61) CA12CA1CA2CA7CA9
SCHEMBL5693510 0.83 NPC1 (0.55) CA12CA1CA2CA7CA9
SCHEMBL10962426 0.83 CA12 (0.61) CA12CA1CA2CA7CA9
SCHEMBL8244593 0.81 ALDH1A1 (0.61) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5155113-A Administering 5-fluorouracil and derivatives with pyridine and pyridone derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-10-13 US disclosed
EP-0180188-B1 A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-04-15 EP disclosed
US-4914206-A ANTIBIOTICS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1990-04-03 US disclosed
EP-0226896-A2 Lankacidin derivatives and production thereof Takeda Chemical Industries, Ltd. (JP) 1987-07-01 EP disclosed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 EP disclosed